Syncope, Vasovagal Clinical Trial
Official title:
The Effect of Capsaicin-Phenylephrine-Caffeine Formulation on Aborting Tilt Induced Syncope in Patients With a History of Vasovagal Syncope or Near Syncope
Syncope is defined as transient loss of consciousness associated with inability to maintain postural tone with rapid and spontaneous recovery. The purpose of this study is to assess the effects of sublingual administration of a new medication called CPC on tilt-induced syncope in patients with a history of vasovagal syncope (VVS) or near syncope. 140 participants were randomized at the University of Wisconsin - Madison. Each participant will be in the study for 1 day.
Vasovagal syncope (VVS) is the most common type of syncope. The mechanism is reflex-mediated triggered by various afferent input to the brain. The event is usually preceded by diaphoresis, warmth, nausea, and pallor, and is followed by fatigue. While several drugs are indicated in the treatment of VVS, to our knowledge, there is no current treatment of an impending syncopal attack. In the present study, the investigators hypothesize that a single administration of sublingual CPC preparation during the prodromal phase aborts tilt-induced syncope or near syncope with SBP less than or equal to 70 mmHg in patients with a history of VVS. Patients with an established diagnosis of typical VVS or near syncope will be randomized to receive CPC or placebo in 1:1 ratio. Drug or placebo will be administered at the onset of prodromes during tilt table testing. In addition to the primary endpoint (syncope or near syncope with SBP less than or equal to 70 mmHg), the investigators will be assessing the effects of the drug on time to event, incidence of asystole (> 3 sec), and fatigue after tilt table testing. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05555771 -
Paediatric Syncope in the Emergency Department
|
N/A | |
Completed |
NCT06038708 -
Head-up Tilt Test in Patients With Reflex Syncope and Asystolic Response Who Received a Dual-chamber Pacemaker With the Closed Loop Stimulation (CLS) and Participated in the BIOSync Trial
|
||
Recruiting |
NCT03159156 -
Respiration and Applied Tension Strategies to Reduce Vasovagal Reactions to Blood Donation
|
N/A | |
Not yet recruiting |
NCT05572034 -
Cardiac Autonomic Denervation for Cardio-inhibitory Syncope
|
N/A | |
Completed |
NCT05729724 -
Effect of Pharmacological Interventions on Systolic Blood Pressure Drops (SynABPM 2 Proof-of-concept)
|
||
Recruiting |
NCT04595942 -
Midodrine and Fludrocortisone for Vasovagal Syncope
|
Phase 3 | |
Completed |
NCT03903744 -
Cardioneuroablation for Reflex Syncope
|
N/A | |
Completed |
NCT05782647 -
Wearable Monitor in Patients With Syncope
|
N/A | |
Completed |
NCT00465439 -
Safety/Efficacy Study of Local Anesthetic Prior to Femoral Artery Sheath Removal
|
N/A | |
Active, not recruiting |
NCT01621464 -
Closed Loop Stimulation for Neuromediated Syncope (SPAIN Study)
|
Phase 4 | |
Recruiting |
NCT06458140 -
Cardioneuroablation and Ventricular Proarrhythmia
|
N/A | |
Recruiting |
NCT06440291 -
Cardioneuroablation for Reflex Syncope and Exercise Capacity
|
N/A | |
Recruiting |
NCT06336031 -
Impact of Blood Phobia on Fainting Susceptibility
|
N/A | |
Completed |
NCT01617616 -
Tilt Table With Suspected Postural Orthostatic Tachycardia Syndrome (POTS) Subjects
|
N/A | |
Recruiting |
NCT05086679 -
Compression Stockings for Treating Vasovagal Syncope Trial
|
N/A | |
Completed |
NCT04772755 -
Presyncope (Syncope) Prevention Study
|
N/A | |
Completed |
NCT03533829 -
Preventing Post-Vaccination Presyncope and Syncope in Adolescents Using Simple, Clinic-based Interventions: A Pilot Study
|
N/A | |
Completed |
NCT05782699 -
Detecting Syncope by an Integrated Multisensor Patch-type Recorder
|
N/A | |
Completed |
NCT01695525 -
Influence of Yoga in Patients With Neurocardiogenic Syncope
|
Phase 0 | |
Completed |
NCT00475462 -
The Effectiveness of Metoprolol in the Prevention of Syncope Recurrence in Children and Adolescents
|
N/A |